Maximise Your Preclinical Model Toolbox by Leveraging Lessons Learned to Confidently Guide Your IO Clinical Decisions

Celebrate 10 Years of Tumour Models With us!

 

The 10th PREDiCT: Tumour Models London Summit will return this December, dedicated to bringing together a community of preclinical and translational scientists with a common goal: narrowing the preclinical gap and progressing efficacious candidates to the clinic.

With the immuno-oncology field constantly evolving and the large breadth of novel therapeutics emerging, it is vital to stay up-to-date on the advances to improve predictability and translatability in models of disease. Delve into how different models are being applied to understand the interactions in the tumour micro-environment, explore resistance mechanisms, effectively translate efficacy, and closer predict in-human effects.

Join us in person this December to:

  • Empower your model toolbox to drive comprehensive and robust data to boost your translational confidence
  • Recapitulate the human environment to produce more predictive models, narrow the preclinical gap and guide clinical decisions
  • Explore advances in humanised mice, SEMMs, PDX, GEMMs, complex organoids and more
  • Deep dive into the latest approaches for personalised medicine in IO to understand which method suits your study and ultimately provide the best medicine for the patient
  • Effectively translate efficacy to drive clinical success and invigorate your pipeline

From early discovery to the early clinic, our packed schedule across 3-days will offer you a comprehensive view of how leading biopharma and expert academics are progressing their IO, targeted and combination therapeutics.

Our World Class Speaker Faculty Includes:

Danilo Maddalo

Head of Laboratory

Roche

Ann White

Senior Principal Scientist

UCB Celltech

Thomas Jaquin

Principle Scientist & In Vivo Team Leader

Pieris

Helena Rannikmae

Senior Scientist, Complex In Vitro Models

GlaxoSmithKline

Anita Seshire

Head of Laboratory in Exploratory Cancer Research

Merck & Co

Barbara Cipriani

Head of Biology

Pathios Therapeutics

Philip Beer

Head of Research & Translational Science

Step Pharma

Martin Knight

Professor of Mechanobiology

Queen Mary University of London

Past Attendees Include:

CMTID Companies (3)

What Past Attendees Have Said:

Proud To Partner With:

crownbio-logo